Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LUNA INNOVATIONS INCLUNA · Entity 84494 | 10% owner | September 04, 2019 | September 06, 2019 |
| Runway Growth Finance Corp.NONE · Entity 6030 | 10% owner | May 10, 2019 | May 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LUNA INNOVATIONS INC
Report date September 04, 2019 · Filed September 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 864,330 |
Ending reported balance
After 2019-09-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-09-04 · Sale · Disposed 71,701 · Balance 964,330 F1: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.25 - $6.38 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Row 2 · 2019-09-05 · Sale · Disposed 48,953 · Balance 915,377 F2: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.60 - $6.86 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Row 3 · 2019-09-06 · Sale · Disposed 51,047 · Balance 864,330 |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.25 - $6.38 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price.
F2: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.60 - $6.86 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price.
Runway Growth Finance Corp.
Report date May 10, 2019 · Filed May 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 1,739,836.99 |
Reported balance
After 2019-05-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-05-10 · Purchase · Acquired 293,571.77 · Balance 1,739,836.99 F1: The number of shares includes shares acquired pursuant to the Runway Growth Credit Fund Inc. automatic dividend reinvestment plan ("DRIP"), exempt under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares includes shares acquired pursuant to the Runway Growth Credit Fund Inc. automatic dividend reinvestment plan ("DRIP"), exempt under Rule 16a-11.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2019 Filed Sep 6, 2019 17:02 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 51,047 | $6.70 | $342,014.90 |
DisclosureSEC source: 0001239819-19-000121 · wf-form4_156780372697262.xml · nonDerivative · entry 3 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 864,330 Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 17:02 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 48,953 | $6.71 | $328,474.63 |
DisclosureSEC source: 0001239819-19-000121 · wf-form4_156780372697262.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,377 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.60 - $6.86 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 17:02 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 71,701 | $6.32 | $453,150.32 |
DisclosureSEC source: 0001239819-19-000121 · wf-form4_156780372697262.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,330 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.25 - $6.38 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 16:53 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 83,634 | $6.39 | $534,421.26 |
DisclosureSEC source: 0001239819-19-000113 · wf-form4_156763036162648.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,031 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.31 - $6.44 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 16:53 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 53,265 | $6.35 | $338,232.75 |
DisclosureSEC source: 0001239819-19-000113 · wf-form4_156763036162648.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,665 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.19 - $6.42 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 16:30 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 81,796 | $6.21 | $507,953.16 |
DisclosureSEC source: 0001239819-19-000109 · wf-form4_156719704160955.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,172,930 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.18 - $6.25 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 16:30 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 109,604 | $6.30 | $690,505.20 |
DisclosureSEC source: 0001239819-19-000109 · wf-form4_156719704160955.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254,726 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.18 - $6.38 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 17:13 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 47,780 | $6.22 | $297,191.60 |
DisclosureSEC source: 0001239819-19-000107 · wf-form4_156702678464415.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,364,330 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.15 - $6.34 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 26, 2019 Filed Aug 28, 2019 17:13 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 52,220 | $6.25 | $326,375.00 |
DisclosureSEC source: 0001239819-19-000107 · wf-form4_156702678464415.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412,110 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.20 - $6.38 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 16:22 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 48,301 | $6.07 | $293,187.07 |
DisclosureSEC source: 0001239819-19-000105 · wf-form4_156659171367445.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,464,330 Read SEC document |
| August 21, 2019 Filed Aug 21, 2019 16:56 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 1,500 | $6.01 | $9,015.00 |
DisclosureSEC source: 0001239819-19-000103 · wf-form4_156642099469244.xml · nonDerivative · entry 3 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,564,330 Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 16:22 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 51,699 | $6.06 | $313,295.94 |
DisclosureSEC source: 0001239819-19-000105 · wf-form4_156659171367445.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,512,631 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.03 - $6.10 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 16:56 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 68,732 | $6.04 | $415,141.28 |
DisclosureSEC source: 0001239819-19-000103 · wf-form4_156642099469244.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,565,830 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.00 - $6.08 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 16:56 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 29,768 | $6.02 | $179,203.36 |
DisclosureSEC source: 0001239819-19-000103 · wf-form4_156642099469244.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,634,562 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $6.00 - $6.05 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:47 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 55,969 | $5.57 | $311,747.33 |
DisclosureSEC source: 0001239819-19-000101 · wf-form4_156598841553750.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,664,330 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.50 - $5.65 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:47 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 23,336 | $5.62 | $131,148.32 |
DisclosureSEC source: 0001239819-19-000101 · wf-form4_156598841553750.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,720,299 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.50 - $5.66 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 16:54 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 36,834 | $5.70 | $209,953.80 |
DisclosureSEC source: 0001239819-19-000099 · wf-form4_156581604417065.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,743,635 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.59 - $5.87 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 16:54 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 83,861 | $5.61 | $470,460.21 |
DisclosureSEC source: 0001239819-19-000099 · wf-form4_156581604417065.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780,469 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.50 - $5.89 per share, inclusive. The reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 18:29 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 54,495 | $5.25 | $286,098.75 |
DisclosureSEC source: 0001239819-19-000097 · wf-form4_156538975661999.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,864,330 Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:51 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 3,305 | $5.25 | $17,351.25 |
DisclosureSEC source: 0001239819-19-000091 · wf-form4_156477908485943.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,918,825 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transactions reported was $5.25 to $5.28 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 16:51 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 42,200 | $5.35 | $225,770.00 |
DisclosureSEC source: 0001239819-19-000091 · wf-form4_156477908485943.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,922,130 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.25 - $5.51 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 29, 2019 Filed Jul 30, 2019 17:03 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 17,178 | $5.02 | $86,233.56 |
DisclosureSEC source: 0001239819-19-000089 · wf-form4_156452056637744.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,964,330 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transactions reported was $5.00 to $5.03 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:03 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 7,154 | $5.00 | $35,770.00 |
DisclosureSEC source: 0001239819-19-000089 · wf-form4_156452056637744.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,981,508 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.01 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 25, 2019 Filed Jul 26, 2019 19:11 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 1,113 | $5.00 | $5,565.00 |
DisclosureSEC source: 0001239819-19-000087 · wf-form4_156418268813622.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,988,662 Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 19:11 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 13,466 | $5.00 | $67,330.00 |
DisclosureSEC source: 0001239819-19-000087 · wf-form4_156418268813622.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989,775 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.01 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 23, 2019 Filed Jul 24, 2019 17:06 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 5,590 | $5.01 | $28,005.90 |
DisclosureSEC source: 0001239819-19-000085 · wf-form4_156400235231482.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003,241 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.02 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 17:06 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 87,960 | $5.02 | $441,559.20 |
DisclosureSEC source: 0001239819-19-000085 · wf-form4_156400235231482.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,008,831 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.085 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 19, 2019 Filed Jul 22, 2019 17:03 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 30,208 | $5.00 | $151,040.00 |
DisclosureSEC source: 0001239819-19-000083 · wf-form4_156382941636996.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,096,791 F2 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.01 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 17:03 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 17,196 | $5.00 | $85,980.00 |
DisclosureSEC source: 0001239819-19-000083 · wf-form4_156382941636996.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,126,999 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 - $5.02 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 17, 2019 Filed Jul 18, 2019 16:55 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 2,835 | $5.00 | $14,175.00 |
DisclosureSEC source: 0001239819-19-000081 · wf-form4_156348330381434.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,144,195 Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 16:55 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 17,300 | $5.02 | $86,846.00 |
DisclosureSEC source: 0001239819-19-000081 · wf-form4_156348330381434.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,147,030 F1 · price: Price reflected is a weighted-average sale price for the shares sold. The range of sales prices for the transaction reported was $5.00 -$5.11 per share, inclusive. The reporting person undertakes to provide upon request of the staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:52 UTC | Runway Growth Finance Corp. NONE · Entity 6030 | PurchaseCommon Stock, par value $0.01 per share | 293,571.77 | $15.16 | $4,450,548.03 |
DisclosureSEC source: 0001144204-19-026159 · tv521452_4.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,739,836.99 F1 · balance_after: The number of shares includes shares acquired pursuant to the Runway Growth Credit Fund Inc. automatic dividend reinvestment plan ("DRIP"), exempt under Rule 16a-11. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:04 UTC | Runway Growth Finance Corp. NONE · Entity 6030 | PurchaseCommon Stock, par value $0.01 per share | 395,305.66 | $15.19 | $6,004,692.98 |
DisclosureSEC source: 0001144204-19-000660 · tv510362_form4.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409,038.32 F1 · balance_after: The number of shares includes shares acquired pursuant to the Runway Growth Credit Fund Inc. automatic dividend reinvestment plan ("DRIP"), exempt under Rule 16a-11. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 17:42 UTC | Runway Growth Finance Corp. NONE · Entity 6030 | PurchaseCommon Stock, par value $0.01 per share | 181,529.76 | $15.02 | $2,726,577.00 |
DisclosureSEC source: 0001144204-18-049887 · tv503013_form4.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,720.32 F1 · balance_after: The number of shares includes shares acquired pursuant to the Runway Growth Credit Fund Inc. automatic dividend reinvestment plan ("DRIP"), exempt under Rule 16a-11. Read SEC document |
| July 17, 2018 Filed Jul 18, 2018 16:43 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | OtherWarrant (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001239819-18-000062 · wf-form4_153194661445975.xml · derivative · entry 4 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-12-31 F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| July 17, 2018 Filed Jul 18, 2018 16:43 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | OtherWarrant (right to buy) · Derivative | 149,097 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001239819-18-000062 · wf-form4_153194661445975.xml · derivative · entry 3 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 149,097 shares Expires 2020-12-31 F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| July 17, 2018 Filed Jul 18, 2018 16:43 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | OtherCommon Stock | 159,097 | $2.50 | $397,742.50 |
DisclosureSEC source: 0001239819-18-000062 · wf-form4_153194661445975.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164,330 Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 16:43 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 39,497 | $3.40 | $134,289.80 |
DisclosureSEC source: 0001239819-18-000062 · wf-form4_153194661445975.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,005,233 F1 · price: Price reflected is a weighted-average sale price for shares sold. The range of sales prices for the transactions reported was $3.40 to $3.42 per share, inclusive. The reporting person undertakes to provide upon request by the staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:06 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 8,955 | $3.40 | $30,447.00 |
DisclosureSEC source: 0001239819-18-000060 · wf-form4_153135757751808.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,044,730 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:12 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 100 | $3.40 | $340.00 |
DisclosureSEC source: 0001239819-18-000049 · wf-form4_152814671757166.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,053,685 Read SEC document |
| May 29, 2018 Filed May 30, 2018 17:08 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 600 | $3.40 | $2,040.00 |
DisclosureSEC source: 0001239819-18-000045 · wf-form4_152771447266219.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,053,785 Read SEC document |
| May 25, 2018 Filed May 30, 2018 17:08 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 6,100 | $3.41 | $20,801.00 |
DisclosureSEC source: 0001239819-18-000045 · wf-form4_152771447266219.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054,385 F1 · price: Price reflected is a weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.40 to $3.42 per share. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2018 Filed May 23, 2018 16:37 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 915 | $3.40 | $3,111.00 |
DisclosureSEC source: 0001239819-18-000044 · wf-form4_152710784389478.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060,485 Read SEC document |
| May 18, 2018 Filed May 21, 2018 17:04 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 100,835 | $3.40 | $342,839.00 |
DisclosureSEC source: 0001239819-18-000043 · wf-form4_152693665279482.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,061,400 Read SEC document |
| May 17, 2018 Filed May 21, 2018 17:04 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 2,095 | $3.40 | $7,123.00 |
DisclosureSEC source: 0001239819-18-000043 · wf-form4_152693665279482.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162,235 Read SEC document |
| May 15, 2018 Filed May 17, 2018 17:05 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | Exercise / conversionWarrant (right to buy) · Derivative | 88,886 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001239819-18-000035 · wf-form4_152659112083673.xml · derivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,097 Underlying: Common Stock · 88,886 shares Expires 2020-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| May 15, 2018 Filed May 17, 2018 17:05 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | OtherCommon Stock | 88,886 | $2.50 | $222,215.00 |
DisclosureSEC source: 0001239819-18-000035 · wf-form4_152659112083673.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164,330 Read SEC document |
| May 09, 2018 Filed May 10, 2018 17:39 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 22,754 | $3.40 | $77,363.60 |
DisclosureSEC source: 0001628280-18-006618 · wf-form4_152598837970933.xml · nonDerivative · entry 2 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075,444 F2 · price: Price reflected is a weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.40 to $3.41 per share, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2018 Filed May 10, 2018 17:39 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 41,854 | $3.44 | $143,977.76 |
DisclosureSEC source: 0001628280-18-006618 · wf-form4_152598837970933.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,098,198 F1 · price: Price reflected is a weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.40 to $3.46 per share, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2018 Filed May 7, 2018 16:29 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | SaleCommon Stock | 3,900 | $3.40 | $13,260.00 |
DisclosureSEC source: 0001239819-18-000029 · wf-form4_152572495826019.xml · nonDerivative · entry 1 Carilion Clinic · CIK 0001363589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,140,052 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.